NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted Emergency Use Authorization for a Zika assay from Luminex, the firm announced today.

The test, called the xMAP MultiFLEX Zika RNA Assay, was designed by Luminex partner GenArraytion, a Rockville, Maryland-based diagnostics maker. The xMAP test is authorized to detect viral RNA in blood or serum, as well as urine samples collected and tested in conjunction with blood or serum. It will be provided to labs that are CLIA certified to run highly complex tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jul
24
Sponsored by
Qiagen

In this webinar, Dr. Fergus Couch from the Mayo Clinic will present data from a large study that used a targeted sequencing panel to determine pancreatic cancer risk associated with inherited mutations in several cancer predisposition genes.

Jul
25
Sponsored by
Streck

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms. 

Aug
09

In this two-part webinar, Dr. Elin Gray, from Edith Cowan University, and Ms. Weiwei Zhao, from Kingmed diagnostic, will compare the highly sensitive, multiplexed UltraSEEK technology, on the MassARRAY system, to digital droplet PCR (ddPCR) results on melanoma and non-small cell lung carcinoma samples.